Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -495.80K | 820.40K | -2.09M | -1.49M | -2.28M |
| Total Depreciation and Amortization | 1.60K | 1.60K | 1.60K | 4.10K | 4.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.40K | -1.27M | 1.58M | 1.00M | 1.75M |
| Change in Net Operating Assets | 156.70K | 309.90K | 148.90K | 396.10K | 233.40K |
| Cash from Operations | -326.00K | -138.40K | -362.00K | -91.70K | -294.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 500.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 869.20K | -- | -- | -- | -- |
| Cash from Investing | 869.20K | -- | -- | 0.00 | 500.00 |
| Total Debt Issued | 0.00 | 35.00K | 593.00K | 25.00K | 117.50K |
| Total Debt Repaid | -12.00K | 0.00 | -115.00K | 0.00 | -57.50K |
| Issuance of Common Stock | -- | -- | -- | 30.00K | 225.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | -12.00K | 35.00K | 478.00K | 55.00K | 285.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 531.30K | -103.40K | 116.00K | -36.70K | -9.20K |